[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$inmb
Inmune Bio terminates $75M at-the-market sales agreement with RBC Capital Markets and BTIG, having previously raised $10.5M. The company's CORDStrom platform shows therapeutic potential in a peer-reviewed study.
About $inmb
Inmune Bio is a biotechnology company focused on developing therapies for cancer and neurodegenerative diseases.
Insights
- $inmb sentiment is up XXXXXX% from the previous X months.
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX +25%
X Months: XXXXXXXXXX +2,195%
X Year: XXXXXXXXXX +4,509%
1-Year High: XXXXXXXXX on 2025-09-16
1-Year Low: XX on 2024-12-25
Engagements by network (24h): X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XX -XX%
X Month: XXX +38%
X Months: XXXXXX +12,658%
X Year: XXXXXX +12,294%
1-Year High: XXXXXX on 2025-07-04
1-Year Low: X on 2024-12-25
Mentions by network (24h): X: XX
Creators: X (24h)
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $inmb in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XXX
X Week: XX -XX%
X Month: XXX +21%
X Months: XXXXXX +15,492%
X Year: XXXXXX +15,631%
1-Year High: XXXXX on 2025-07-04
1-Year Low: X on 2025-12-07
The most influential creators that mention $inmb in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXX |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% +50%
X Month: XXX% +60%
X Months: XXX% no change
X Year: XXX% no change
1-Year High: XXX% on 2024-12-13
1-Year Low: X% on 2025-09-16
Most Supportive Themes:
- Alzheimer's Disease Results Presentation: (10%) Inmune Bio will present Phase X Alzheimer's disease results for Pegipanermin on December 1st.
- Intellectual Property Strategy: (5%) Josh Schoonover, Inmune Bio's in-house counsel, leads the company's IP strategy and has driven significant patent acquisitions.
Most Critical Themes:
- Short and Gamma Squeeze Mentions: (30%) Multiple posts mention $INMB in the context of potential short and gamma squeezes, alongside numerous other tickers.
- Options Trading Mentions: (25%) $INMB is mentioned in the context of options trading, including put options, with varying sentiment.
- Stock Performance Comparisons: (20%) $INMB is mentioned alongside other stocks in discussions about performance, including predictions of significant drops.
Top $inmb Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🧒 Honestly the best financial Twitter/Telegram/Channel follow I have is Prof. @zmmm__o. Free professional and incredibly useful signals.#Futures #sstvi $GPUS #Tech🦕 $IART #Cryptocurrency🏰 $ABBV #P/BRatio🎎 $JBI #Restructuring🥑 $INMB"
X Link @GangwishNe88697 2025-12-11T15:30Z X followers, XX engagements
"🤰🤿 For those asking how I find my trading ideas: I follow Prof. @LarThone's free daily alerts. His analysis as a finance professor is next level. #SP500 #NXXTFedBoost $BULL #ShortSelling🐄 $INTT #BlackSwanEvent👮 $IMA #ElectricVehicles🎍 $ITOS #MergersandAcquisitions👠 $INMB"
X Link @MDearco57177 2025-12-11T05:19Z X followers, XX engagements
"$INMB low vol but - INmune Bio Terminates $75M At-the-Market Sales Agreement With RBC Capital Markets And $BTIG Effective December XX 2025; Prior To Termination The Co Issued And Sold 1353469 Shares Of Common Stock Under The Sales Agreement Raising Net Proceeds Of$10.5M"
X Link @thestockblog 2025-12-11T04:13Z 6073 followers, XXX engagements
"Top breakouts since yesterday $INMB $WRBY $TRIB at 9:06am pst"
X Link @BreakoutStocks 2025-12-09T17:06Z 115.4K followers, XXX engagements